Effect on Wound Healing of Vigamox Versus Cravit
NCT00840580 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 79
Last updated 2012-07-23
Summary
The purpose of this study was to compare the effects of Vigamox and Cravit on corneal wound healing after cataract surgery.
Conditions
- Cataract Extraction
Interventions
- DRUG
-
Moxifloxacin 0.5% ophthalmic solution (Vigamox)
One drop 4 times a day in study eye for one week prior to surgery, followed by one drop 4 times a day for two weeks beginning Day 1 post surgery.
- DRUG
-
Levofloxacin 0.5% ophthalmic solution (Cravit)
One drop 4 times a day in study eye for one week prior to surgery, followed by one drop 4 times a day for two weeks beginning Day 1 post surgery.
Sponsors & Collaborators
-
Alcon Research
lead INDUSTRY
Principal Investigators
-
Eung Kweon Kim, MD/PhD · Severance Hospital, Yousei University College of Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-01-31
- Primary Completion
- 2009-09-30
Countries
- South Korea
Study Locations
More Related Trials
-
Postoperative Safety Outcomes of Intraoperative Intracameral Preservative-Free Moxifloxacin Versus Levofloxacin
NCT04403334 ·Status: COMPLETED ·Phase: PHASE4
-
Levofloxacin Ocular Implant for Ocular Surgery
NCT04682288 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Ocular Penetration of Topically Administered Fluoroquinolones
NCT00924729 ·Status: COMPLETED ·Phase: PHASE4
-
Ocular Tissue Levels of 1.5% Levofloxacin Ophthalmic Solution Compared to an Active Comparator
NCT00630019 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract Surgery
NCT06164743 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Efficacy and Safety of Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis.
NCT02770729 ·Status: TERMINATED ·Phase: PHASE3
-
Effect of Topical Fluoroquinolones on Epithelial Wound Healing After PRK
NCT00569881 ·Status: COMPLETED
-
A Comparison of Prophylactic Antibacterial Efficacy of Besivance vs. VIGAMOX Prior to Cataract Surgery
NCT01296542 ·Status: COMPLETED ·Phase: PHASE4
-
Safety Profile Comparison of Undiluted Intracameral Moxifloxacin vs. Levofloxacin in Cataract Surgery
NCT05741632 ·Status: COMPLETED ·Phase: PHASE1
-
Prospective Randomized Comparison of Zymar(Gatifloxacin) and Vigamox (Moxifloxacin) in Killing Conjunctival Bacterial Flora Following a One-hour Application
NCT00466570 ·Status: WITHDRAWN ·Phase: NA
-
Intracameral Levofloxacin (0.5%) vs Intracameral Cefuroxime
NCT04212078 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Comparison of Three Fluoroquinolone Topical Eyedrops in the Treatment of Infectious Corneal Ulcers.
NCT01928693 ·Status: TERMINATED ·Phase: PHASE2
-
Dosage Study for Vigamox Eye Drops Prior to Intravitreal Injections
NCT00690313 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Moxifloxacin Versus Gatifloxacin on Corneal Epithelium Following Pterygium Excision
NCT00892918 ·Status: UNKNOWN ·Phase: NA
-
Study of DE-108 Ophthalmic Solution in Patients Who Are Scheduled for Cataract Surgery
NCT02573610 ·Status: COMPLETED ·Phase: PHASE3
-
Aqueous Absorption and Pharmacokinetics of Besivance Versus VIGAMOX in Patients Undergoing Phacoemulsification
NCT01296191 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Moxifloxacin/Prednisolone in Prevention of Post Surgery Inflammation
NCT01603030 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract Surgery
NCT00575380 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia After Refractive Surgery
NCT01643252 ·Status: WITHDRAWN ·Phase: PHASE3
-
The Usefulness of Visuprime in Cataract Surgery
NCT06533995 ·Status: COMPLETED ·Phase: NA
-
2-Site Safety Study of Besivance Versus Vigamox Prophylactically in Routine Cataract Surgery
NCT01455233 ·Status: COMPLETED ·Phase: PHASE4
-
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
NCT01024322 ·Status: TERMINATED
-
Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects
NCT00824070 ·Status: COMPLETED ·Phase: PHASE1
-
Measurement of Antioxidant Activity on Postoperative Inflammation in Patients Undergoing Ophthalmic Surgery
NCT05905237 ·Status: COMPLETED
-
Comparison of Treatment With Preservative-free Dexamethasone 0.1% (Monofree Dexamethason) and Diclofenac 0.1% (Dicloabak) Eye Drops Versus Preserved Dexamethasone 0.1% (Maxidex) and Diclofenac 0.1% (Voltaren Ophtha) Eye Drops After Cataract Surgery
NCT04050644 ·Status: RECRUITING ·Phase: PHASE4